List of Tables 6
List of Figures 6
Takeda Pharmaceutical Company Limited Spshot 7
Takeda Pharmaceutical Company Limited Overview 7
Key Information 7
Key Facts 7
Takeda Pharmaceutical Company Limited - Research and Development Overview 8
Key Therapeutic Areas 8
Takeda Pharmaceutical Company Limited - Pipeline Review 15
Pipeline Products by Stage of Development 15
Pipeline Products - Monotherapy 16
Pipeline Products - Combition Treatment Modalities 17
Pipeline Products - Partnered Products 18
Pipeline Products - Out-Licensed Products 20
Takeda Pharmaceutical Company Limited - Pipeline Products Glance 22
Takeda Pharmaceutical Company Limited - Late Stage Pipeline Products 22
Takeda Pharmaceutical Company Limited - Clinical Stage Pipeline Products 25
Takeda Pharmaceutical Company Limited - Early Stage Pipeline Products 28
Takeda Pharmaceutical Company Limited - Drug Profiles 33
(alogliptin benzoate + metformin hydrochloride) 33
(alogliptin benzoate + pioglitazone hydrochloride) 35
brentuximab vedotin 38
ceftaroline fosamil 45
ixazomib citrate 48
ramelteon 53
vedolizumab 55
roflumilast 57
(amlodipine besylate + azilsartan medoxomil + hydrochlorothiazide) 62
azilsartan medoxomil 63
febuxostat XR 65
immune globulin (human) 66
pioglitazone hydrochloride 68
rasagiline mesylate 70
relugolix 71
TAK-003 72
vortioxetine hydrobromide 75
AM-4 78
DSM-265 79
milumab 81
TAK-063 83
TAK-214 85
TAK-272 87
TAK-850 88
J-591 90
TAK-020 91
TAK-021 92
TAK-058 93
TAK-071 94
TAK-079 95
TAK-653 96
TAK-792 97
TAK-828 98
TAK-831 99
TAK-915 100
TAK-935 101
trelagliptin succite 102
(plague + small pox) vaccine 104
BTZO-2 105
chikungunya vaccine 106
ELQ-300 107
influenza [strain A/H5N1] vaccine 108
influenza [strains A/H1N1 + A/H3N2 + A/H5N1] (virus like particle) vaccine 109
mapatumumab 110
Monoclol Antibody Conjugate to Target c-Ret for Breast Cancer 112
Monoclol Antibody Conjugate to Target Guanylyl Cyclase C for Oncology 113
Monoclol Antibody Conjugates for Oncology 114
respiratory syncytial virus (virus like particle) vaccine 115
Rotavirus (virus like particle) vaccine 116
Small Molecule 1 to Inhibit Dopamine Transporter, Noradreline Transporter and Serotonin Transporter for Depression 117
Small Molecule 2 to Inhibit Gamma Secretase for Alzheimer’s Disease 118
Small Molecule to Activate Glucokise for Type 2 Diabetes 119
Small Molecule to Agonize Canbinoid Receptor for Inflammatory Pain 120
Small Molecule to Agonize GPR52 for Psychiatry Disorders 121
Small Molecule to Antagonize Androgen Receptor for Prostate Cancer 122
Small Molecule to Antagonize CRF1 for CNS Disorders 123
Small Molecule to Antagonize Farnesoid X Receptor for Dyslipidemia 124
Small Molecule to Antagonize MCHR1 for Obesity 125
Small Molecule to Antagonize Mineralocorticoid Receptor for Hypertension 126
Small Molecule to Antagonize PDGFR and VEGFR-2 for Oncology 127
Small Molecule to Inhibit Dopamine Transporter, Noradreline Transporter and Serotonin Transporter for Depression 128
Small Molecule to Inhibit FAAH for Pain 129
Small Molecule to Inhibit Gamma Secretase for Alzheimer’s Disease 130
Small Molecule to Inhibit HER2/EGFR for Oncology 131
Small Molecule to Inhibit NET for Stress Uriry Incontinence 132
Small Molecule to Inhibit PKC-Theta 133
Small Molecules for Parkinson’s Disease 134
Small Molecules for Visceral Leishmaniasis 135
Small Molecules to Agonize GPR119 for Type II Diabetes 136
Small Molecules to Inhibit Acetyl-CoA Carboxylase for Obesity 137
Small Molecules to Inhibit B-Raf for Oncology 138
Small Molecules to Inhibit CENP-E for Colon Cancer 139
Small Molecules to Inhibit DPP-IV for Type 2 Diabetes 140
Small Molecules to Inhibit Hedgehog Sigling for Medulloblastoma 141
Small Molecules to Inhibit MAP2 for Obesity 142
Small Molecules to Inhibit MGAT2 for Metabolic Disorders 143
Small Molecules to Inhibit MMP-13 for Osteoarthritis 144
Small Molecules to Inhibit PARP-1 for Colon Cancer 145
Small Molecules to Inhibit TYK2 146
Stem Cell Therapy for Muscular Dystrophy 147
T-1840383 148
T-3256336 149
TAK-041 150
TAK-480 151
TAK-632 152
Y-443 153
Small Molecule for Undisclosed Indication 154
Small Molecule to Inhibit Arginine Methyltrasferase for Oncology 155
Small Molecule to Inhibit HDAC6 156
Small molecules for Leishmaniasis and Trypanosomiasis 157
Small Molecules for Malaria 158
Small Molecules for Tuberculosis 159
Small Molecules to Inhibit Apoptosis Sigl-Regulating Kise 1 160
Small Molecules to Inhibit FAK for Oncology 161
Small Molecules to Inhibit HER2 and EGFR for Oncology 162
Small Molecules to Inhibit IAP for Oncology 163
Small Molecules to Inhibit Mcl-1 and Bcl-xL for Oncology 164
Y-142 165
Takeda Pharmaceutical Company Limited - Pipeline Alysis 166
Takeda Pharmaceutical Company Limited - Pipeline Products by Target 166
Takeda Pharmaceutical Company Limited - Pipeline Products by Route of Administration 176
Takeda Pharmaceutical Company Limited - Pipeline Products by Molecule Type 177
Takeda Pharmaceutical Company Limited - Pipeline Products by Mechanism of Action 178
Takeda Pharmaceutical Company Limited - Recent Pipeline Updates 188
Takeda Pharmaceutical Company Limited - Dormant Projects 232
Takeda Pharmaceutical Company Limited - Discontinued Pipeline Products 235
Discontinued Pipeline Product Profiles 237
Takeda Pharmaceutical Company Limited - Company Statement 246
Takeda Pharmaceutical Company Limited - Locations And Subsidiaries 247
Head Office 247
Other Locations & Subsidiaries 247
Appendix 257
Methodology 257
Coverage 257
Secondary Research 257
Primary Research 257
Expert Panel Validation 257
Contact Us 257
Disclaimer 258